FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, Nov 30, 2017
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on November 30, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 41fbc22e-37e0-4057-b95d-f3701e59c7b6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1032363
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.188(a)Accurate reproduction
- 21 CFR 211.56(b)Written sanitation procedures not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of QuVa Pharma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2025 | OAI | New Jersey District Office | Drug Quality Assurance |
| October 14, 2022 | OAI | Drug Quality Assurance | |
| May 31, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.